Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation

Cell Biochemistry and Function

Volumn 21, Issue 4, 2003, Pages 371-375

  Serhatlioglu, Selami ^a   Gursu, M Ferit ^a   Gulcu, Funda ^a   Canatan, Halit ^a   Godekmerdan, Ahmet ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Ionizing radiation; Malondialdehyde; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; LIPID; MALONALDEHYDE; SODIUM CHLORIDE; TRACE ELEMENT; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; ENZYME ACTIVITY; FEMALE; HOMOZYGOTE; HUMAN; IONIZING RADIATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOLOGY; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION; WORKER;

ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FEMALE; HUMANS; LIPIDS; MALE; MALONDIALDEHYDE; OCCUPATIONAL EXPOSURE; PHENOTYPE; RADIATION, IONIZING; SEX FACTORS;

EID: 0344392687     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1042     Document Type: Article

References (18)

1. Mackness MI, Thompson HM, Hardy AR, Walker CH. Distinction between a-esterases and arylesterases. Implications for esterase classification. Biochem J 1987; 245: 293-296.
2. La Du BN, Adkins S, Bayoumi RA. Analysis of the serum paraoxonase/arylesterase polymorphism in some Sudanese families. Prog Clin Biol Res 1986; 214: 87-98.
3. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100-106.
4. Tanaka-Kawai H, Yomoda S. Molecular weight and substrate characteristics of human serum arylesterase following purification by immuno-affinity chromatography. Clin Chim Acta 1993; 215: 127-138.
5. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 1995; 15: 1812-1818.
6. Li WF, Costa LG, Furlong CE. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health 1993; 40: 337-346.
7. Nishio E, Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem Biophys Res Commun 1997; 236: 289-293.
8. Eckerson HW, Romson J, Wyte C, La Du BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1983; 35: 214-227.
9. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303-1309.
10. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 473-480.
11. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993; 49: 566-576.
12. Ruiz J, Blanche H, James RW, et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869-872.
13. Juretic D, Tadijanovic M, Rekic B, Simeon-Rudolf V, Reiner E, Baricic M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J 2001; 42: 146-150.
14. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984; 105: 328-331.
15. Garin MC, James RW, Dussoix P, et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997; 99: 62-66.
16. Mackness B, Mackness MI, Arrol S, Turkei W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998; 423: 57-60.
17. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69-76.
18. Sozmen EY, Sozmen B, Girgin FK, et al. Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation. Clin Exp Med 2001; 1: 195-199.